Annis Gardner Whiting Capital Advisors, LLC Abb Vie Inc. Transaction History
Annis Gardner Whiting Capital Advisors, LLC
- $357 Billion
- Q4 2024
A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 4,545 shares of ABBV stock, worth $879,230. This represents 0.23% of its overall portfolio holdings.
Number of Shares
4,545
Previous 4,305
5.57%
Holding current value
$879,230
Previous $850 Million
4.99%
% of portfolio
0.23%
Previous 0.24%
Shares
6 transactions
Others Institutions Holding ABBV
# of Institutions
4,020Shares Held
1.28BCall Options Held
18.3MPut Options Held
13.4M-
Vanguard Group Inc Valley Forge, PA173MShares$33.5 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.4 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$15.3 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$10 Billion0.75% of portfolio
-
Morgan Stanley New York, NY38.7MShares$7.49 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $342B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...